SunWay Biotech Co., LTD. (TPEX:1271)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
57.90
-1.60 (-2.69%)
Feb 11, 2026, 2:33 PM CST
Market Cap3.50B -16.9%
Revenue (ttm)951.52M +17.3%
Net Income84.86M -21.4%
EPS1.40 -35.0%
Shares Out60.39M
PE Ratio41.35
Forward PEn/a
Dividend1.33 (2.30%)
Ex-Dividend DateJul 16, 2025
Volume99,631
Average Volume81,195
Open59.00
Previous Close59.50
Day's Range57.00 - 59.20
52-Week Range48.60 - 90.80
Beta-0.09
RSI47.18
Earnings DateMar 20, 2026

About SunWay Biotech Co., LTD.

SunWay Biotech Co., LTD. focuses on professional research and development, and technical material manufacturing and processing business. The company offers red yeast rice and lactic acid bacteria products, as well as other health supplements; and wholesale and manufacturing of pharmaceutical products. The company also researches, designs, and manufactures Monascus purpureus NTU 568; Lactobacillus paracasei subsp. paracasei NTU 101; and related products. The company was founded in 2007 and is based in Taipei, Taiwan. [Read more]

Founded 2007
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 1271
Full Company Profile

Financial Performance

In 2024, SunWay Biotech Co., LTD.'s revenue was 970.18 million, an increase of 69.88% compared to the previous year's 571.11 million. Earnings were 118.57 million, an increase of 157.26%.

Financial Statements